BIT 3.33% 3.1¢ biotron limited

Ann: Appendix 4C - quarterly, page-12

  1. J8
    14,554 Posts.
    lightbulb Created with Sketch. 823
    Taken on board Red.... but a few points to consider. Someone here posted that they had it on good authority the trial was going to be held here. Perhaps it was, until they found the cost too prohibitive. The trial is funded, according to their budget but the chances of a CR remain very high. All their money is budgeted for already and they will be broke in six months. ASX companies can not operate with six months funds only. They must provide for further ahead or the market will not buy them. Timing of the CR will be when they can get the best deal, I'd say it will be a little before the paper on HIV is released....... and expect some news on Zika too. So far, any CR looks like it will be around 3.5c. I am prepared to buy at that price. This drug may have a future with gene therapy. It is quite apparent that curing HBV and HIV with gene therapy, will probably require chemical help. If they can prove what they are saying about reservoirs, I think there is hope.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $27.97M
Open High Low Value Volume
3.1¢ 3.1¢ 3.0¢ $13.15K 436.6K

Buyers (Bids)

No. Vol. Price($)
6 564909 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 75851 1
View Market Depth
Last trade - 15.26pm 02/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.